(Q41575430)

4 October 2017

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties (English)

1 reference

4 October 2017

1 reference

8

Waldmann H

1 reference

4 October 2017

Bolt S

1

1 reference

4 October 2017

Routledge E

2

1 reference

4 October 2017

Lloyd I

3

1 reference

4 October 2017

Chatenoud L

4

1 reference

4 October 2017

Pope H

5

1 reference

4 October 2017

Gorman SD

6

1 reference

4 October 2017

Clark M

7

1 reference

4 October 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

European Journal of Immunology

4 October 2017

1 reference

4 October 2017

23

1 reference

4 October 2017

2

1 reference

4 October 2017

403-411

1 reference

Isolation of cDNA clones encoding the 20K T3 glycoprotein of human T-cell receptor complex

4 October 2017

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Isolation of cDNA clones encoding the 20K non-glycosylated polypeptide chain of the human T-cell receptor/T3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A new subunit of the human T-cell antigen receptor complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Structure of the T cell antigen receptor (TCR): two CD3 epsilon subunits in a functional TCR/CD3 complex

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

T cell activation by anti-T3 antibodies: comparison of IgG1 and IgG2b switch variants and direct evidence for accessory function of macrophage Fc receptors

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Induction of T cell proliferation with anti-CD3 switch-variant monoclonal antibodies: effects of heavy chain isotype in monocyte-dependent systems

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

In vivo administration of anti-CD3 prevents malignant progressor tumor growth

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Cytotoxic T lymphocyte-mediated lysis via the Fc receptor of target cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Hybrid antibodies can target sites for attack by T cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Monoclonal antibody therapy. Anti-idiotypic and non-anti-idiotypic antibodies to OKT3 arising despite intense immunosuppression

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A rat model for imaging the effect of anti mouse antibody responses on the biodistribution of radiolabelled mouse monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Replacing the complementarity-determining regions in a human antibody with those from a mouse

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Reshaping human antibodies for therapy

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A humanized monovalent CD3 antibody which can activate homologous complement

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Use of monoclonal antibodies to T-cell subsets for immunologic monitoring and treatment in recipients of renal allografts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Molecular definition of interaction sites on human IgG for Fc receptors (huFc gamma R)

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A human beta-actin expression vector system directs high-level accumulation of antisense transcripts

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Arrangement of human immunoglobulin heavy chain constant region genes implies evolutionary duplication of a segment containing gamma, epsilon and alpha genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Sequence of a human immunoglobulin gamma 3 heavy chain constant region gene: comparison with the other human C gamma genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

The sequence of a human immunoglobulin epsilon heavy chain constant region gene, and evidence for three non-allelic genes

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Structure of human immunoglobulin gamma genes: implications for evolution of a gene family

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Expression of spleen cell immunoglobulin phenotype in hybrids with myeloma cell lines

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

An oscillating bubble chamber for laboratory scale production of monoclonal antibodies as an alternative to ascitic tumours

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Isolation and expression of functional high-affinity Fc receptor complementary DNAs

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Human in vivo antigenic modulation induced by the anti-T cell OKT3 monoclonal antibody.

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Recombinant antibodies possessing novel effector functions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Human IgG subclass pattern of inducing complement-mediated cytolysis depends on antigen concentration and to a lesser extent on epitope patchiness, antibody affinity and complement concentration

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

A protein structural change in aglycosylated IgG3 correlates with loss of huFc gamma R1 and huFc gamma R111 binding and/or activation

1 reference

https://api.crossref.org/works/10.1002%2FEJI.1830230216

7 January 2021

Identifiers

DOI

10.1002/EJI.1830230216

1 reference

4 October 2017

1 reference